We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FESTI:OMXICEFesti hf. Analysis

Data as of 2026-06-12 - not real-time

ISK 318.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Festi hf. is trading at ISK 318, just above its 20‑day SMA (321) and comfortably within a narrow 311‑332 range bounded by recent support and resistance. Technicals are mixed: RSI sits at 44.8 (neutral), while the MACD shows a bearish divergence (line –3.40 vs signal –2.95). Volume is increasing, suggesting market participation, but the overall trend remains neutral. Fundamentally, the stock appears stretched – the DCF fair‑value estimate of ~ISK 216 is far below the current price, indicating overvaluation, while the PE of 16.2 and dividend yield of 2.2% are modest. The company generates solid operating cash flow (ISK 13.3 bn) and pays a sustainable dividend (payout ~35%), yet it carries a high debt‑to‑equity ratio (~89) that could limit flexibility.
The recent Q1 2026 results were released on 29 April, reinforcing the existing earnings profile but providing no surprise catalysts. Market sentiment is in “Extreme Greed” territory (Fear‑Greed Index 89.9), which may be inflating the price beyond fundamentals. Investors should weigh the attractive dividend against the valuation gap and leverage risk when deciding on exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above immediate support (311)
  • Bearish MACD histogram signaling short‑term downside pressure
  • Increasing volume indicating active trading but no clear breakout

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Stable dividend yield and payout ratio supporting cash‑flow returns
  • High debt‑to‑equity ratio that could constrain future earnings growth

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Current price far exceeds intrinsic value estimates
  • Elevated leverage (debt‑to‑equity ~89) raises solvency concerns
  • Modest revenue growth (6%) and thin margins limit long‑term upside

Key Metrics & Analysis

Financial Health

Revenue Growth6.00%
Profit Margin3.50%
P/E Ratio16.2
ROE14.09%
ROA5.34%
Debt/Equity88.56
P/B Ratio2.1
Op. Cash FlowISK13.3B
Free Cash FlowISK6.0B

Technical Analysis

TrendNeutral
RSI44.8
SupportISK 311.00
ResistanceISK 332.00
MA 20ISK 321.05
MA 50ISK 327.94
MA 200ISK 323.22
MACDBearish
VolumeIncreasing
Fear & Greed Index89.95

Valuation

Fair ValueISK 216.45
GradeOvervalued
TypeValue
Dividend Yield2.20%

Risk Assessment

Beta0.20
Volatility21.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.